HCW Biologics HCWB
NASDAQ HCWB
$1.16 -0.01 (-0.85%)
At close: Oct 21, 2026 · 4:00 PM EDT

HCW Biologics (HCWB) Short term Debt (2022 - 2025)

Updated

HCW Biologics (HCWB) reported Short term Debt of $6.3 million for Q1 2025, compared with $122,152 a year earlier and unchanged from the prior quarter.

Analysis

HCW Biologics (HCWB) Short term Debt (2022 - 2025) Analysis & Trends

Dating back to Q4 2022, HCW Biologics' Short term Debt record includes 10 quarters.

  • By year, Short term Debt came in at $119,398 in FY2023 (-99.7%) and $38.27 million in FY2022.
  • Five-year quarterly Short term Debt spans a low of $67,979 in Q1 2023 and a high of $38.27 million in Q4 2022.
  • Per Business Quant data, the three quarters before Q1 2025 came in at $6.3 million (Q4 2024), $6.3 million (Q3 2024) and $124,000 (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 HCW Biologics 1.53 Mn -4.70 Mn -93,887.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 6.30 Mn
Dec 31, 2024 6.30 Mn
Sep 30, 2024 6.30 Mn
Jun 30, 2024 124,000.00
Mar 31, 2024 122,152.00
Dec 31, 2023 119,398.00
Sep 30, 2023 117,680.00
Jun 30, 2023 97,101.00
Mar 31, 2023 67,979.00
Dec 31, 2022 38.27 Mn
API Access

HCW Biologics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=HCWB&period=max&api_key=YOUR_API_KEY